Seguimiento farmacoterapéutico en pacientes diabéticos e hipertensos en el centro de salud ESPOCH Lizarzaburu

Abstract

The aim of this study was to carry out pharmacotherapy follow-up in diabetic and hypertensive patients at the Centro de Salud "ESPOCH Lizarzaburu" during March - August 2021, applying a field and descriptive study by means of a mixed research. The study was applied in four stages according to Dáder Method used for pharmacotherapy follow-up, so that, in phase I, the initial situation in patients was analyzed through the review of their clinical history and an interview, later in phase II, possible drug-related problems and negative results associated with medication were identified, which were resolved in phase III with pharmaceutical interventions, to finally be evaluated in phase IV with the help of several tests. It was found that the majority of patients with type II diabetes mellitus were women aged older than 60, with a primary and secondary school level and a body mass index inclined to overweight and obesity, in addition, they used most frequently insulins and angiotensin II receptor antagonists for the treatment of diabetes and hypertension, respectively. It was identified that the main problems related to medications that occurred most frequently were untreated health problems in 29.85%, so that 44.78% of negative results associated with medication were of effectiveness, the 40.30% need and 14.93% safety. It was concluded that pharmacotherapy interventions allow to improve adherence to pharmacological treatment. Finally, it is recommended to continue pharmacotherapy follow-up at the Health Center in order to improve pharmacological adherence and ensure the effectiveness of medications.